Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2020

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Compensation Expense

Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands):

	Three Months Ended March 31,		Three Months Ended March 31,
	2020		2019
Research and development	$	14	$	—
Sales and marketing	4		—
General and administrative	8		—
	$	26	$	—

Stock Options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Options Granted, Exercised, Expired and Forfeited

A summary of stock options expired and forfeited under our plans and options outstanding as of, and changes made during, the three months ended March 31, 2020 and the year ended December 31, 2019 is presented below:

	Outstanding				Exercisable
	Number of Options		Weighted Average Exercise Price		Number of Options	Weighted Average Exercise Price
Options outstanding, December 31, 2018	118,003		$	19.90	118,003	$	19.90
Exchanged for Oblong Industries stock options	107,845		4.92
Exercised	—		—
Expired	(440	)	16.48
Forfeited	(10,063	)	23.20
Options outstanding, December 31, 2019	215,345		12.27		215,345	12.27
Options outstanding and exercisable, March 31, 2020	215,345		$	12.27	215,345	$	12.27

Shares Outstanding and Exercisable, By Exercise Price Range

Additional information as of March 31, 2020 is as follows:

	Outstanding and Exercisable
Range of price	Number of Options	Weighted Average Remaining Contractual Life (In Years)	Weighted Average Exercise Price
$0.00 – $10.00	110,345	0.56	$	5.01
$10.01 – $20.00	97,500	2.81	19.32
$20.01 – $30.00	2,500	2.19	21.80
$30.01 – $40.00	5,000	1.95	30.20
	215,345	1.63	$	12.27

Restricted Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Share Activity

A summary of restricted stock granted, vested and unvested outstanding as of, and changes made during, the three months ended March 31, 2020 and the year ended December 31, 2019, is presented below:

	Restricted Shares		Weighted Average Grant Date Price
Unvested restricted stock outstanding, December 31, 2018	11,320		$	14.88
Granted	0		—
Vested	(1,372	)	15.72
Forfeited	(9,321	)	14.70
Unvested restricted stock outstanding, December 31, 2019	627		15.80
Unvested restricted stock outstanding, March 31, 2020	627		$	15.80

Schedule of Compensation Expense

Stock-based compensation expense relating to restricted stock awards is allocated as follows (in thousands):

	Three Months Ended March 31,		Three Months Ended March 31,
	2020		2019
General and administrative	—		2
	$	—	$	2

RSUs

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Share Activity

A summary of restricted stock units (“RSUs”) granted, vested, forfeited and unvested outstanding as of, and changes made during, the three months ended March 31, 2020 and the year ended December 31, 2019, is presented below:

	Restricted Stock Units		Weighted Average Grant Price
Unvested restricted stock units outstanding, December 31, 2018	503,518		$	1.94
Granted	55,479		1.30
Vested	(114,505	)	3.05
Forfeited	(421,158	)	1.54
Unvested restricted stock units outstanding, December 31, 2019	23,334		2.20
Unvested restricted stock units outstanding, March 31, 2020	23,334		$	2.20

Schedule of Compensation Expense

Stock-based compensation expense relating to restricted stock units is allocated as follows (in thousands):

	Three Months Ended March 31,		Three Months Ended March 31,
	2020		2019
Cost of revenue	$	—	$	4
Research and development	—		4
Sales and marketing	—		19
General and administrative	6		27
	$	6	$	54